Second Case of PML Reported in Person Receiving Gilenya®/About-the-Society/News/Second-Case-of-PML-Reported-in-Person-Receiving-Gi … read morePosted At: National MS Society
Preliminary Results of MS Prevalence Study Estimate Nearly 1 Million Living with MS in the U.S./About-the-Society/News/Preliminary-Results-of-MS-Prevalence-Study … read morePosted At: National MS Society
CorrigendumMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Federal Government Shutdown’s Possible Impact on People with MS/About-the-Society/News/Federal-Government-Shutdown-s-Possible-Impact-on-P … read morePosted At: National MS Society
Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies
Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studiesMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS...
- Next story Study Finds That the Antibiotic Minocycline May Reduce the Likelihood of Transitioning to Definite M
- Previous story New Study Explores Changes in “Social Cognition” in People with MS
Join Our Mailing List
- World’s Largest MS Research Conference: Understanding MS and New Strategies to Restore Function
- Conceptual framework to study role of exercise in multiple sclerosis
- Insights into microbiome research 3: Who’s there versus what are they doing?
- Updates From ECTRIMS Research Conference
- Environmental factors may trigger onset of multiple sclerosis
- Genetic Ancestry Associated with Clinical Course in Hispanic-Latinos: Study is Ongoing
- Prognostic information for people with MS: Impossible or inevitable?
- New immunotherapy targeting blood-clotting protein
- Animal models of multiple sclerosis: From rodents to zebrafish
- Inclusion criteria used in trials of people with progressive multiple sclerosis